NDC 50458-606
Invega Trinza 273 mg per 0.88 mL injection, suspension, extended release
On the label: Janssen Pharmaceuticals, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Janssen Pharmaceutica NV | Beerse, Belgium | Makes it, tests it and packages it | Problems found, fixed voluntarilySep 5, 2025 · 8 inspections |
| Janssen Pharmaceutical Sciences Unlimited Company | Co Cork, Ireland | Makes the active ingredient | Problems found, fixed voluntarilyOct 27, 2023 · 5 inspections |
| Eurofins PHAST GmbH | Homburg, Germany | Tests it | Problems found, fixed voluntarilyDec 13, 2023 · 4 inspections |
| Janssen Pharmaceuticals, Inc. | Titusville, NJ, United States | Tests it | Problems found, fixed voluntarilySep 25, 2026 · 11 inspections |
| Janssen-Cilag Manufacturing, LLC | Gurabo, PR, United States | Tests it | Problems found, fixed voluntarilyFeb 11, 2026 · 6 inspections |
Product details
- Generic drug
- Paliperidone: every company that makes it
- Form
- injection, suspension, extended release, intramuscular
- Strength
- 273 mg per 0.88 mL
- Approval
- NDA NDA207946
- On the market since
- May 19, 2015
- Package NDCs
50458-606-01- Official label
- DailyMed (National Library of Medicine), updated Feb 14, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?